Clinical trial
Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease…
NCT00390767 · MultiGene Vascular Systems Ltd., Industry · Unknown status
Key facts
| NCT number | NCT00390767 |
|---|---|
| Title | Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) |
| Official title | A Phase I Safety, Dose Escalating Study of MultiGeneAngio in Patients With Peripheral Arterial Disease |
| Lead sponsor | MultiGene Vascular Systems Ltd., Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | PAD, Claudication |
| Intervention type | Biological |
| Interventions | MultiGeneAngio |
| Enrollment | 12 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2024 |
| First posted | Oct 20, 2006 |
| Last update posted | Mar 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: